Long-term negative impact on quality of life in patients with successfully treated Cushing's disease

Clinical Endocrinology

Volumn 61, Issue 4, 2004, Pages 458-465

  Heald, Adrian H ^a   Ghosh, Sandip ^a   Bray, Stephanie ^a   Gibson, Christine ^b   Anderson, Simon G ^a   Buckler, Helen ^a   Fowler, Helen L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CUSHING DISEASE; ENDOCRINE DISEASE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY; GENERAL HEALTH QUESTIONNAIRE 28; HOSPITAL ANXIETY AND DEPRESSION SCALE UK VERSION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SOCIAL ADJUSTMENT SCALE MODIFIED; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SURGICAL TECHNIQUE; WELLBEING; WORLD HEALTH ORGANIZATION QUALITY OF LIFE SCALE ABBREVIATED VERSION;

ADENOMA; ADULT; ANIMALS; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PITUITARY NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SOCIAL BEHAVIOR; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 6344223713     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02118.x     Document Type: Article

References (39)

1. Baird, A., Sullivan, T., Zafar, S. & Rock, J. (2003) Quality of life in patients with pituitary tumours: a preliminary study. Quality Management in Health Care, 12, 97-105.
2. Bjelland, I., Dahl, A.A., Haug, T.T. & Neckelmann, D. (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52, 69-77.
3. Bourdeau, I., Bard, C., Noël, B., Leclerc, I., Cordeau, M.P., Bélair, M., Lesage, J., Lafontaine, L. & Lacroix, A. (2002) Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. Journal of Clinical Endocrinology and Metabolism, 87, 1949-1954.
4. Bulow, B., Hagmar, L., Orbaek, P., Osterberg, K. & Erfurth, E.M. (2002) High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clinical Endocrinology, 56, 183-193.
5. Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S.B., Winicour, P. & Brannon, J. (1993) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579.
6. Cohen, S.I. (1980) Cushing's syndrome: a psychiatric study of 29 patients. British Journal of Psychiatry, 136, 120-124.
7. Cooper, P., Osborn, M., Gath, D. & Feggeter, G. (1982) Evaluation of a modified self-report measure of social adjustment. British Journal of Psychiatry, 141, 68-75.
8. Crawford, J.R., Henry, J.D., Crombie, C. & Taylor, E.P. (2001) Normative data for the HADS from a large non-clinical sample. British Journal of Clinical Psychology, 40, 429-434.
9. Cushing, H. (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bulletin of the Johns Hopkins Hospital, 50, 137-195.
10. Dorn, L.D., Burgess, E.S., Dubbert, B., Simpson, S.E., Friedman, T., Kling, M., Gold, P.W. & Chrousos, G.P. (1995) Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features. Clinical Endocrinology, 434, 33-42.
11. Fang, C.T., Hsiuing, P.C., Yu, C.F., Chen, M.Y. & Wang, J.D. (2002) Validation of the World Health Organisation quality of life instrument in patients with HIV infection. Quality of Life Research, 11, 753-762.
12. Goldberg, O.P. & Hillier, V.F. (1979) A scaled version of the General Health Questionnaire. Psychological Medicine, 9, 138-145.
13. Grattan-Smith, P.J., Morris, J.G.L., Shores, E.A., Batchelor, J. & Sparks, R.S. (1992) Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurologica, 86, 626-631.
14. Hermann, C. (1997) International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17-41.
15. Holmes, S.J. & Shalet, S.M. (1995) Factors influencing the desire for long-term growth hormone replacement in adults. Clinical Endocrinology, 43, 151-157.
16. Kaltsas, G.A., Isidori, A.M., Florakis, D., Trainer, P.J., Camacho-Hubner, C., Afshar, F., Sabin, I., Jenkins, J.P., Chew, S.L., Monson, J.P., Besser, G.M. & Grossman, A.B. (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Journal of Clinical Endocrinology and Metabolism, 86, 1645-1652.
17. Kelly, W.F. (1996) Psychiatric aspects of Cushing's syndrome. Quarterly Journal of Medicine, 89, 543-551.
18. Kelly, W.F., Checkley, S.A., Bender, D.A. & Mashiter, K. (1983) Cushing's syndrome and depression - a prospective study of 26 patients. British Journal of Psychiatry, 142, 16-19.
19. Kelly, W.F., Kelly, M.J. & Faragher, B. (1996) A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clinical Endocrinology, 45, 715-720.
20. Kling, M.A., Roy, A., Doran, A.R., Calabrese, J.R., Rubinow, D.R., Whitfield, H.J.J.R., May, C., Post, R.M., Chrousos, G.P. & Gold, P.W. (1991) Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. Journal of Clinical Endocrinology and Metabolism, 72, 260-271.
21. Korali, Z., Wottchen, H.U., Pfister, H., Hofler, M., Oefelein, W. & Stalla, G.K. (2003) Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatrica Scandinavica, 107, 60-68.
22. Lynch, S., Merson, S., Beshyah, S.A., Skinner, E., Sharp, P., Priest, R.G. & Johnston, D.G. (1994) Psychiatric morbidity in adults with hypopituitarism. Journal of the Royal Society of Medicine, 87, 445-441.
23. McGauley, G.A. (1989) Quality of life assessment in adults before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica, 356 (Suppl.), 55-59.
24. Momose, K.J., Kjellberg, R.N. & Kliman, B. (1971) High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Radiology, 99, 341-348.
25. Monson, J.P. (2003) Long term experience with GH replacement therapy. European Journal of Endocrinology, 148 (Suppl. 2), S9-S14.
26. Pacak, K., Tjurmina, O., Palkovits, M., Goldstein, D.S., Koch, C.A., Hoff, T. & Chrousos, G.P. (2002) Chronic hypercortisolaemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study. Neuroendocrinology, 76, 148-157.
27. Page, R.C.L., Hammersley, M.S., Burke, C.W. & Wass, J.A.H. (1997) An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clinical Endocrinology, 46, 401-406.
28. Peace, K.A., Orme, S.M., Sebastian, A.R., Thomson, S., Barnes, A., Ellis, A. & Belchetz, P.E. (1997) The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clinical Endocrinology, 46, 445-450.
29. Peace, K.A., Orme, S.M., Padayatty, S.J., Godfrey, H.P.D. & Belchetz, P.E. (1998) Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clinical Endocrinology, 49, 391-196.
30. Regestein, Q.R., Rose, L.I. & Williams, G.H. (1972) Psychopathology in Cushing's syndrome. Archives of Internal Medicine, 130, 114-117.
31. Rosen, T., Bosaeus, I., Tolli, J., Lindstedt, J. & Bengtsson, B.A. (1994) Decreased well being in adult patients with growth hormone deficiency. Clinical Endocrinology, 40, 111-116.
32. Simmons, N.B., Do, H.M., Lipper, M.H. & Laws, E.R. Jr (2000) Cerebral atrophy in Cushing's disease. Surgical Neurology, 53, 72-76.
33. Spillane, J.D. (1951) Nervous and mental disorders in Cushing's syndrome. Brain, 74, 72-94.
34. Starkman, M.N., Gebarski, S.S., Berent, S. & Schteingart, D.E. (1992) Hippocampal formation volume, memory dysfunction, and Cortisol levels in patients with Cushing's syndrome. Biological Psychiatry, 32, 756-765.
35. Streiner, D.I. & Norman, G.R. (1995) Health Measurement Scales: A Practical Guide to their Development and Use, 2nd edn. Oxford University Press, Oxford.
36. The WHOQOL Group (1998) Development of the World Health Organisation WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551-558.
37. Wallymahmed, M.E., Foy, P. & MacFarlane, I.A. (1999) The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clinical Endocrinology, 51, 333-338.
38. Yellan, S.B., Cella, D.F., Webster, K., Blendowski, C. & Kaplan, E. (1997) Measuring fatigue and anaemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain Symptom Management, 13, 63-74.
39. Zigmond, A.S. & Snaith, R.P. (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.